XGENE
XGene focuses on developing ultra-small, long-distance and high-precision automotive binocular technology that can be used on self-driving cars, drones, robotics and other smart devices. The automatic collision avoidance binocular system developed by the company is being integrated by Chinese logistics firms, drones and self-driving cars, XGene said without giving out details.
XGENE
Industry:
Developer Tools Electronics
Founded:
2011-01-01
Address:
Taiwan, Jiangsu, China
Country:
China
Total Employee:
1+
Status:
Active
Total Funding:
10 M USD
Current Employees Featured
Meiyu Gu Founder, CEO & Chairman @ XGene
Founder, CEO & Chairman
Founder
Investors List
CAIF
CAIF investment in Series A - XGene
The Hina Group
The Hina Group investment in Series A - XGene
More informations about "XGene"
Xgene Pharmaceutical - Crunchbase Company Profile …
Xgene Pharmaceutical is a late-clinical stage, venture-backed international company that uses proprietary linker technology to develop novel, multimodal …See details»
Xgene Pharmaceutical - LinkedIn
Xgene Pharmaceutical Inc. is a late-clinical stage, venture capital-backed, international company utilizing their proprietary linker technology to create novel, multimodal, conjugated molecules ...See details»
News - Xgene Pharmaceutical Inc.
Mar 11, 2025 Xgene Pharmaceutical Inc. Announces Dosing of First Patient in a Phase 2b/3 Trial of XG005 for the Treatment of Pain Following Bunionectomy Surgery. August 23,2023. ...See details»
XGene - Crunchbase Company Profile & Funding
XGene focuses on developing ultra-small, long-distance and high-precision automotive binocular technology that can be used on self-driving cars, drones, …See details»
XGene - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Sep 28, 2016: Series A - …See details»
Organization | Xgene Pharmaceutical
Organization Overview. First Clinical Trial. 2017 NCT04499209. First Marketed Drug. None First NDA Approval. None ... Xgene Pharmaceutical Group | Xgene Pharmaceutical Pty Ltd Active …See details»
Xgene - LinkedIn
Xgene is currently in the role of internal supplier to Hof Therapeutics Inc. | Xgene Corporation has focused on enabling core technologies to advance human ability to have our biology work for us ...See details»
About Us - Xgene Pharmaceutical Inc.
Established in 2015, Xgene Pharmaceutical Inc. engineers high-impact medications for unmet underserved needs in neurological conditions. Xgene’s proprietary linker technology generates …See details»
Xgene Pharmaceutical 2025 Company Profile: …
Xgene Pharmaceutical was founded in 2015. Where is Xgene Pharmaceutical headquartered? Xgene Pharmaceutical is headquartered in Taipei, Taiwan. What industry is Xgene Pharmaceutical in? Xgene Pharmaceutical’s primary …See details»
Xgene Pharmaceutical, Inc. - Drug pipelines, Patents, Clinical trials ...
100 Deals associated with Xgene Pharmaceutical, Inc. Login to view more data. 100 Translational Medicine associated with Xgene ... full example data. Pipeline. Pipeline Snapshot as of 04 Mar …See details»
Our Science - Xgene Pharmaceutical Inc.
Xgene’s innovative platform provides a unique multimodal approach to address the complex multifaceted dimensions of pain therapies. By leveraging medications with mechanisms of …See details»
Xgene (Biotechnology) 2025 Company Profile: Valuation, Funding ...
Xgene (Biotechnology) General Information Description. Developer of biomedical products intended to provide medical and cosmetic advances ready for production use. The company's …See details»
XG004 - Drug Targets, Indications, Patents - Synapse
Mar 20, 2025 XG004, Initially developed by Xgene Pharmaceutical, Inc., Now, its global highest R&D status is Phase 2, Therapeutic Areas: Nervous System Diseases,Immune System …See details»
Xgene Pharmaceutical - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised ... obfuscated. obfuscated. CITIC Securities, …See details»
Xgene - Products, Competitors, Financials, Employees, …
Xgene is a biotechnology company focused on advancing regenerative medicine and component manufacturing. The company specializes in assembling stem cells into functional tissues and …See details»
Xgene Pharma of Shanghai Closes $20 Million B Round for Pain …
Oct 25, 2018 Xgene Pharma, a Shanghai start-up, raised $20 million in series B financing round led by Ping An Ventures. Xgene's lead product, a combination of naproxen and pregabalin …See details»
X-gene - Wikipedia
Main page; Contents; Current events; Random article; About Wikipedia; Contact us; Pages for logged out editors learn moreSee details»
Xgene Pharmaceutical - Contacts, Employees, Board Members, …
Organization. Xgene Pharmaceutical . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 2. ... Xgene …See details»
The disease-specific structural pattern in Parkinson’s disease and …
12 hours ago Brain structure characteristics form the basis on regulating neuroplastic processes by genes, and structural alterations may contribute to the progression of Parkinson’s disease …See details»
Xgene Pharmaceutical Announces Positive Topline Results from …
Xgene’s drug discovery areas include pain and CNS conditions focusing research on finding treatments and cures to unmet medical needs. We collaborate with health care providers, …See details»